{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:12:32Z","timestamp":1780762352843,"version":"3.54.1"},"reference-count":70,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Background: Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract illness and hospitalizations in children aged \u22645 years worldwide. The aim of this study was to characterize the Polish population of patients aged \u22645 years who were hospitalized due to RSV infection, focusing on their clinical and epidemiological characteristics as well as treatment patterns. Methods: This retrospective observational study was conducted between November 2023 and February 2024 in 41 hospitals with pediatric departments across Poland. Data from patients aged \u22645 years admitted due to RSV infection confirmed with antigen test or RT-PCR were collected. The dataset was weighted and extrapolated to allow conclusions applicable to the general population of patients aged 0\u20135 years hospitalized with RSV infection in Poland. Results: Data from 419 patients were analyzed. Over half (57.4%) were younger than 12 months, 84% were born at term, and 85.8% had no comorbidities. The most frequent manifestations of RSV infections were pneumonia (56.8%), bronchiolitis (35.9%), and bronchitis (12.4%). Viral co-infections were identified in 8% of patients. Regarding treatment, 21.1% of patients required respiratory support, 67.6% received inhaled steroid therapy, 61.5% were treated with antibiotics, 48.1% received beta2-mimetics and anticholinergics, and 44.3% underwent systemic steroid therapy. Conclusions: Our findings confirm that severe RSV primarily affects the youngest children with no comorbidities who do not present high risk conditions. To reduce the overall disease burden, preventive strategies should be offered to all children, not being limited to those in risk groups.<\/jats:p>","DOI":"10.3390\/v18010060","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:34:23Z","timestamp":1767198863000},"page":"60","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Burden and Healthcare Utilization Associated with Hospitalizations of RSV-Infected Polish Children During the 2022\/23 Season"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-6759","authenticated-orcid":false,"given":"Jan","family":"Mazela","sequence":"first","affiliation":[{"name":"Department of Neonatology, Poznan University of Medical Sciences in Poznan, 60-535 Pozna\u0144, Poland"},{"name":"Department of Pediatrics, Collegium Medicum, University of Zielona G\u00f3ra, 65-046 Zielona G\u00f3ra, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-7854","authenticated-orcid":false,"given":"Teresa","family":"Jackowska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7292-1712","authenticated-orcid":false,"given":"Marcin","family":"Czech","sequence":"additional","affiliation":[{"name":"Department of Pharmacoeconomics, Hospital Infection Control Team, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Helwich","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Neonatal Intensive Care, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Martyn","sequence":"additional","affiliation":[{"name":"Sanofi A\/S, Vaccines Medical Affairs, DK-2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Aleksiejuk","sequence":"additional","affiliation":[{"name":"Sanofi Sp. z o. o., Vaccines Medical Affairs, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-6378","authenticated-orcid":false,"given":"Anna","family":"Smaga","sequence":"additional","affiliation":[{"name":"PEX Sp. z o. o., 02-796 Warsaw, Poland"},{"name":"National Institute of Public Health NIH\u2014National Research Institute, 00-791 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Tkacz","sequence":"additional","affiliation":[{"name":"PEX Sp. z o. o., 02-796 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-9727","authenticated-orcid":false,"given":"Joanna","family":"Glazewska","sequence":"additional","affiliation":[{"name":"PEX Sp. z o. o., 02-796 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5360-5826","authenticated-orcid":false,"given":"Jacek","family":"Wysocki","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Poznan University of Medical Sciences at Poznan, 61-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcv.2010.03.002","article-title":"Etiology of bronchiolitis in a hospitalized pediatric population: Prospective multicenter study","volume":"48","author":"Antunes","year":"2010","journal-title":"J. Clin. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/irv.12665","article-title":"Evaluation of using ICD-10 code data for respiratory syncytial virus surveillance","volume":"14","author":"Cai","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/infdis\/jiw475","article-title":"Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children","volume":"215","author":"Heikkinen","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/infdis\/jiy056","article-title":"Respiratory Syncytial Virus Seasonality: A Global Overview","volume":"217","author":"Sly","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ppul.23570","article-title":"Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis","volume":"52","author":"Stein","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/infdis\/jiac137","article-title":"Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged \u22645 Years (INSPIRE Study)","volume":"226","author":"Hartmann","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e2416077","DOI":"10.1001\/jamanetworkopen.2024.16077","article-title":"Pediatric Respiratory Syncytial Virus Hospitalizations, 2017\u20132023","volume":"7","author":"Fitzpatrick","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_10","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am. J. Dis. Child."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13052-024-01628-7","article-title":"Clinical and economic burden of respiratory syncytial virus in children aged 0\u20135 years in Italy","volume":"50","author":"Dovizio","year":"2024","journal-title":"Ital. J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/ciy991","article-title":"Severe Morbidity and Mortality Associated with Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults","volume":"69","author":"Ackerson","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Barr, R., Green, C.A., Sande, C.J., and Drysdale, S.B. (2019). Respiratory syncytial virus: Diagnosis, prevention and management. Ther. Adv. Infect. Dis., 6.","DOI":"10.1177\/2049936119865798"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00431-014-2277-7","article-title":"Clinical and epidemiologic factors related to subsequent wheezing after virus-induced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years","volume":"173","author":"Takeyama","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40121-016-0123-0","article-title":"Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries","volume":"5","author":"Bont","year":"2016","journal-title":"Infect. Dis. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cis211","article-title":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993\u20132008","volume":"54","author":"Zhou","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13052-021-01148-8","article-title":"Epidemiology and prevention of respiratory syncytial virus infections in children in Italy","volume":"47","author":"Azzari","year":"2021","journal-title":"Ital. J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2328950","DOI":"10.1001\/jamanetworkopen.2023.28950","article-title":"Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak","volume":"6","author":"Halasa","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_20","unstructured":"(2025, November 27). Medonet Webpage. Available online: https:\/\/www.medonet.pl\/choroby-od-a-do-z\/choroby-zakazne,to-choroba--ktora-wraca-co-roku--tym-razem-uderzyla-wczesniej-i-mocniej,artykul,05541292.html."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/infdis\/jiac227","article-title":"Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings","volume":"226","author":"Langley","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jpids\/piz011","article-title":"Respiratory Syncytial Virus-Associated Outpatient Visits Among Children Younger Than 24 Months","volume":"8","author":"Lively","year":"2019","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1883379","DOI":"10.1080\/21645515.2021.1883379","article-title":"Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017","volume":"18","author":"Walter","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Murray, J., Bottle, A., Sharland, M., Modi, N., Aylin, P., Majeed, A., and Saxena, S. (2014). Risk factors for hospital admission with RSV bronchiolitis in England: A population-based birth cohort study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089186"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jpids\/piz087","article-title":"Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014\u20132015","volume":"9","author":"Arriola","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gatt, D., Martin, I., AlFouzan, R., and Moraes, T.J. (2023). Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens, 12.","DOI":"10.3390\/pathogens12020154"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13052-015-0203-x","article-title":"Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)","volume":"41","author":"Bollani","year":"2015","journal-title":"Ital. J. Pediatr."},{"key":"ref_29","unstructured":"Agency, E.M. (2024, July 15). Beyfortus (Nirsevimab) for the Treatment of Serious Lower Respiratory Tract Infection Caused by RSV in Infants and Children During Their First RSV Season. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/beyfortus#authorisation-details-section."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s40265-025-02224-7","article-title":"Clesrovimab: First Approval","volume":"85","author":"Syed","year":"2025","journal-title":"Drugs"},{"key":"ref_31","unstructured":"(2024, August 20). European Commission Approves Pfizer\u2019s ABRYSVO\u2122 to Help Protect Infants Through Maternal Immunization and Older Adults from RSV. Available online: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/european-commission-approves-pfizers-abrysvotm-help-protect."},{"key":"ref_32","unstructured":"(2024, August 20). U.S. FDA Approves ABRYSVO\u2122, Pfizer\u2019s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32\u201336 Weeks of Gestational Age. Available online: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/us-fda-approves-abrysvotm-pfizers-vaccine-prevention-0."},{"key":"ref_33","unstructured":"(2024, August 20). RSV Vaccine and mAb Snapshot. Available online: https:\/\/www.path.org\/our-impact\/resources\/rsv-vaccine-and-mab-snapshot\/."},{"key":"ref_34","unstructured":"(2024, August 20). Polish Drug Program Annex B.40. Prophylaxis of Respiratory Syncytial Virus (RSV) Infections, Available online: https:\/\/www.gov.pl\/attachment\/cc4459ad-6bcf-4139-8748-bafc9187905b."},{"key":"ref_35","unstructured":"(2025, November 27). Webapage, Available online: https:\/\/szczepienia.pzh.gov.pl\/faq\/jak-finansowane-sa-szczepionki-przeciw-rsv\/."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41467-022-30485-3","article-title":"Off-season RSV epidemics in Australia after easing of COVID-19 restrictions","volume":"13","author":"Eden","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e002453","DOI":"10.1136\/fmch-2023-002453","article-title":"Time trend and seasonality in medically attended respiratory syncytial virus (RSV) infections in US children aged 0\u20135 years, January 2010\u2013January 2023","volume":"11","author":"Wang","year":"2023","journal-title":"Fam. Med. Community Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.eclinm.2023.102089","article-title":"Why has the epidemiology of RSV changed during the COVID-19 pandemic?","volume":"61","author":"Reicherz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mazela, J., Jackowska, T., Czech, M., Helwich, E., Martyn, O., Aleksiejuk, P., Smaga, A., Glazewska, J., and Wysocki, J. (2024). Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years. Viruses, 16.","DOI":"10.3390\/v16050704"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Loconsole, D., Centrone, F., Rizzo, C., Caselli, D., Orlandi, A., Cardinale, F., Serio, C., Giordano, P., Lassandro, G., and Milella, L. (2022). Out-of-Season Epidemic of Respiratory Syncytial Virus during the COVID-19 Pandemic: The High Burden of Child Hospitalization in an Academic Hospital in Southern Italy in 2021. Children, 9.","DOI":"10.3390\/children9060848"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(22)00525-4","article-title":"Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: A retrospective observational study","volume":"23","author":"Bardsley","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Thindwa, D., Li, K., Cooper-Wootton, D., Zheng, Z., Pitzer, V.E., and Weinberger, D.M. (2024). Global patterns of rebound to normal RSV dynamics following COVID-19 suppression. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09509-4"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e2416852","DOI":"10.1001\/jamanetworkopen.2024.16852","article-title":"Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic","volume":"7","author":"Winthrop","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/cid\/ciae140","article-title":"Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of SARS-CoV-2 Can Be Attributed to Changes in Testing","volume":"78","author":"Petros","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e247125","DOI":"10.1001\/jamanetworkopen.2024.7125","article-title":"Respiratory Syncytial Virus Hospital-Based Burden of Disease in Children Younger Than 5 Years, 2015\u20132022","volume":"7","author":"Suss","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2023065623","DOI":"10.1542\/peds.2023-065623","article-title":"Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016\u20132022","volume":"154","author":"McMorrow","year":"2024","journal-title":"Pediatrics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e14083","DOI":"10.1111\/pai.14083","article-title":"Age-specific predictors of disease severity in children with respiratory syncytial virus infection beyond infancy and through the first 5\u2009years of age","volume":"35","author":"Eisner","year":"2024","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e13066","DOI":"10.1111\/irv.13066","article-title":"Burden and severity of children\u2019s hospitalizations by respiratory syncytial virus in Portugal, 2015\u20132018","volume":"17","author":"Bandeira","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Viguria, N., Mart\u00ednez-Baz, I., Moreno-Galarraga, L., Sierrases\u00famaga, L., Salcedo, B., and Castilla, J. (2018). Respiratory syncytial virus hospitalization in children in northern Spain. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206474"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13052-023-01455-2","article-title":"Hospitalization for bronchiolitis in children aged \u22641 year, Southern Italy, year 2021: Need for new preventive strategies?","volume":"49","author":"Baldassarre","year":"2023","journal-title":"Ital. J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kobia\u0142ka, M., Jackowska, T., and Wrotek, A. (2023). Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children. Viruses, 15.","DOI":"10.3390\/v15081713"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1093\/infdis\/jiac216","article-title":"Expected Impact of Universal Immunization with Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model","volume":"226","author":"Kieffer","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e13211","DOI":"10.1111\/irv.13211","article-title":"Inpatient burden of respiratory syncytial virus in children \u22642\u2009years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019\u20132022","volume":"17","author":"Wick","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13052-024-01617-w","article-title":"Respiratory syncytial virus-associated hospitalizations among children: An Italian retrospective observational study","volume":"50","author":"Fortunato","year":"2024","journal-title":"Ital. J. Pediatr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"113491","DOI":"10.1016\/j.jpeds.2023.113491","article-title":"Respiratory Syncytial Virus, Influenza, and Coronavirus Disease 2019 Hospitalizations in Children in Colorado During the 2021\u20132022 Respiratory Virus Season","volume":"260","author":"Rao","year":"2023","journal-title":"J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annepidem.2024.04.010","article-title":"Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015\u20132023","volume":"94","author":"Blatt","year":"2024","journal-title":"Ann. Epidemiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1093\/infdis\/jiac244","article-title":"All infants are at risk of developing medically attended respiratory syncytial virus lower respiratory tract infection and deserve protection","volume":"226","author":"Hodges","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/infdis\/jiac203","article-title":"Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age","volume":"226","author":"Movva","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/pch\/4.3.195","article-title":"Analysis of antibiotic use and misuse in children hospitalized with RSV infection","volume":"4","author":"Samson","year":"1999","journal-title":"Paediatr. Child. Health"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e13268","DOI":"10.1111\/irv.13268","article-title":"Respiratory Syncytial Virus-Associated Hospitalizations in Children: A 10-Year Population-Based Analysis in Finland, 2008\u20132018","volume":"18","author":"Uusitupa","year":"2024","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/INF.0000000000001981","article-title":"Antibiotic Overuse in Children with Respiratory Syncytial Virus Lower Respiratory Tract Infection","volume":"37","author":"Naaktgeboren","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Proesmans, M., Rector, A., Keyaerts, E., Vandendijck, Y., Vermeulen, F., Sauer, K., Reynders, M., Verschelde, A., Laffut, W., and Garmyn, K. (2022). Risk factors for disease severity and increased medical resource utilization in respiratory syncytial virus (+) hospitalized children: A descriptive study conducted in four Belgian hospitals. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268532"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107712","DOI":"10.1016\/j.pharmthera.2020.107712","article-title":"Pharmacological targets and emerging treatments for respiratory syncytial virus bronchiolitis","volume":"220","author":"Elawar","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12519-023-00777-9","article-title":"Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children","volume":"20","author":"Zhang","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.37201\/req\/147.2023","article-title":"Respiratory syncytial virus: A new era","volume":"37","year":"2024","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_66","first-page":"422","article-title":"Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure","volume":"128","author":"Moler","year":"1996","journal-title":"Pediatric Critical Study Group. J. Pediatr."},{"key":"ref_67","first-page":"372","article-title":"Pediatric Antiviral Stewardship: Defining the Potential Role of Ribavirin in Respiratory Syncytial Virus-Associated Lower Respiratory Illness","volume":"23","author":"Hoover","year":"2018","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/thx.2009.126086","article-title":"Steroids do not improve RSV-related wheeze in children","volume":"64","author":"Tofts","year":"2009","journal-title":"Thorax"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.104.6.e77","article-title":"Prednisolone treatment of respiratory syncytial virus infection: A randomized controlled trial of 147 infants","volume":"104","author":"Nir","year":"1999","journal-title":"Pediatrics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.15557\/PiMR.2023.0056","article-title":"Clinical course and complications of RSV versus non-RSV bronchiolitis in hospitalised children","volume":"19","author":"Jackowska","year":"2023","journal-title":"Pediatr. I Med. Rodz."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/1\/60\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T05:18:16Z","timestamp":1767244696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/1\/60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["v18010060"],"URL":"https:\/\/doi.org\/10.3390\/v18010060","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}